SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Smruthi Organics - Quaterly Results

27 Jul 2024 Evaluate
Net sales declined -21.88%  to  Rs. 272.73 million from Rs. 349.12 millions.The Net Loss for the quarter ended June 2024 is Rs. -9.22 millions as compared to Net Profit of Rs. 22.94 millions of corresponding quarter ended June 2023Operating Profit reported a sharp decline to 4.48 millions from 46.29 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 272.73 349.12 -21.88 272.73 349.12 -21.88 1276.43 1410.41 -9.50
Other Income 0.02 0.11 -81.82 0.02 0.11 -81.82 0.76 1.07 -28.97
PBIDT 4.48 46.29 -90.32 4.48 46.29 -90.32 120.31 98.87 21.69
Interest 4.08 3.25 25.54 4.08 3.25 25.54 14.08 8.22 71.29
PBDT 0.40 43.04 -99.07 0.40 43.04 -99.07 106.23 90.65 17.19
Depreciation 12.94 12.38 4.52 12.94 12.38 4.52 56.53 45.72 23.64
PBT -12.54 30.66 -140.90 -12.54 30.66 -140.90 49.70 44.93 10.62
TAX -3.32 7.72 -143.01 -3.32 7.72 -143.01 13.79 3.63 279.89
Deferred Tax -3.32 -1.13 193.81 -3.32 -1.13 193.81 -2.27 -10.97 -79.31
PAT -9.22 22.94 -140.19 -9.22 22.94 -140.19 35.91 41.30 -13.05
Equity 114.46 114.46 0.00 114.46 114.46 0.00 114.46 114.46 0.00
PBIDTM(%) 1.64 13.26 -87.61 1.64 13.26 -87.61 9.43 7.01 34.46

Smruthi Organics Share Price

112.94 -2.15 (-1.87%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.25
Dr. Reddys Lab 1220.75
Cipla 1232.90
Zydus Lifesciences 928.85
Lupin 2311.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×